Cyclic peptide CXCR4 antagonists

Details for Australian Patent Application No. 2008260326 (hide)

Owner Eli Lilly and Company

Inventors Peng, Sheng-Bin; Yan, Liang Zeng; Kohn, Wayne David

Agent Spruson & Ferguson

Pub. Number AU-B-2008260326

PCT Pub. Number WO2008/150689

Priority 60/940,802 30.05.07 US; 60/940,996 31.05.07 US

Filing date 20 May 2008

Wipo publication date 11 December 2008

Acceptance publication date 21 July 2011

International Classifications

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

C07K 7/54 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/150689 Priority application(s): WO2008/150689

21 July 2011 Application Accepted

  Published as AU-B-2008260326

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008260340-Stackable transport cart

2008260311-Human DR4 antibodies and uses thereof